Digital health platform for chronic disease management, particularly diabetes, using connected devices and AI.
Livongo was a digital health company that specialized in chronic disease management, particularly focused on diabetes care through connected devices and data analytics. The company developed a comprehensive platform that combined glucose monitoring devices, personalized coaching, and AI-driven insights to help patients better manage their health conditions.
Founded to address the growing need for digital health solutions, Livongo gained significant traction in the healthcare technology sector and attracted substantial venture capital investment. The company went public in 2019 and was later acquired by Teladoc Health in 2020 for approximately $18.5 billion, creating one of the largest digital health companies. This acquisition marked a significant milestone in the telehealth and chronic disease management space.
Livongo has received investment from 5 venture capital firms.
Digital health platform for chronic disease management, particularly diabetes, using connected devices and AI.
Livongo has received investment from 7wire Ventures, Flare Capital Partners, Frist Cressey Ventures, General Catalyst, HealthTech Capital. These venture capital firms and investors provide both capital and strategic support.
Livongo operates in the Digital Health sector. Digital health platform for chronic disease management, particularly diabetes, using connected devices and AI.
